OVIVA THERAPEUTICS Trademark

Trademark Overview


On Friday, April 9, 2021, a trademark application was filed for OVIVA THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the OVIVA THERAPEUTICS trademark a serial number of 90634639. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, June 4, 2024. This trademark is owned by Cambrian BioPharma, Inc.. The OVIVA THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the prevention of ovarian disfunction; Pharmaceutical preparations for the prevention of infertility; Pharmaceutical preparations for the prevention of polycystic ovary syndrome; Pharmaceutical preparations for the treatment of ovarian disfunction; Pharmaceutical preparations for the treatment of oncofertoprotection; Pharmaceutical preparations for the treatment of infertility; Pharmaceutical preparations for the treatment of polycystic ovary syndrome; Pharmaceutical preparations for the treatment of reproductive disease; Pharmaceutical preparations for the treatment of neurodegenerative disease; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for evaluating ovarian function; Pharmaceutical preparations for the preservation of ovarian function; Pharmaceutical preparations for the improvement of ovarian function; Pharmaceutical preparations for supporting sex reassignment; Pharmaceutical preparations for contraception;...
oviva therapeutics

General Information


Serial Number90634639
Word MarkOVIVA THERAPEUTICS
Filing DateFriday, April 9, 2021
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, June 4, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 2, 2021

Trademark Statements


Goods and ServicesPharmaceutical preparations for the prevention of ovarian disfunction; Pharmaceutical preparations for the prevention of infertility; Pharmaceutical preparations for the prevention of polycystic ovary syndrome; Pharmaceutical preparations for the treatment of ovarian disfunction; Pharmaceutical preparations for the treatment of oncofertoprotection; Pharmaceutical preparations for the treatment of infertility; Pharmaceutical preparations for the treatment of polycystic ovary syndrome; Pharmaceutical preparations for the treatment of reproductive disease; Pharmaceutical preparations for the treatment of neurodegenerative disease; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for evaluating ovarian function; Pharmaceutical preparations for the preservation of ovarian function; Pharmaceutical preparations for the improvement of ovarian function; Pharmaceutical preparations for supporting sex reassignment; Pharmaceutical preparations for contraception; Pharmaceutical preparations for treating indications of reproductive health
NOT AVAILABLE"THERAPEUTICS"

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, July 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCambrian BioPharma, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNew York, NY 10003

Party NameCambrian BioPharma, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNew York, NY 10003

Trademark Events


Event DateEvent Description
Tuesday, April 13, 2021NEW APPLICATION ENTERED
Saturday, July 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, September 28, 2021ASSIGNED TO EXAMINER
Tuesday, September 28, 2021EXAMINERS AMENDMENT -WRITTEN
Tuesday, September 28, 2021EXAMINERS AMENDMENT E-MAILED
Tuesday, September 28, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 28, 2021EXAMINER'S AMENDMENT ENTERED
Tuesday, September 28, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 13, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 2, 2021PUBLISHED FOR OPPOSITION
Tuesday, November 2, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, December 28, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 21, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, June 21, 2022SOU EXTENSION 1 FILED
Tuesday, June 21, 2022SOU EXTENSION 1 GRANTED
Thursday, June 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 19, 2022SOU TEAS EXTENSION RECEIVED
Monday, December 19, 2022SOU EXTENSION 2 FILED
Monday, December 19, 2022SOU EXTENSION 2 GRANTED
Wednesday, December 21, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 26, 2023SOU TEAS EXTENSION RECEIVED
Monday, June 26, 2023SOU EXTENSION 3 FILED
Monday, June 26, 2023SOU EXTENSION 3 GRANTED
Wednesday, June 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 27, 2023SOU TEAS EXTENSION RECEIVED
Monday, November 27, 2023SOU EXTENSION 4 FILED
Monday, November 27, 2023SOU EXTENSION 4 GRANTED
Wednesday, November 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 29, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, November 29, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, November 29, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, June 4, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 4, 2024SOU EXTENSION 5 GRANTED
Tuesday, June 4, 2024SOU EXTENSION 5 FILED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED